前列腺癌患者的Circulating RNAs Circulating RNAs in prostate cancer patients Mugoni V, Ciani Y, Nardella C, Demichelis F. Circulating RNAs in prostate cancer patients. Cancer Lett. 2022 Jan 1;524:57-69. doi: 10.1016/j.canlet.2021.10.011. Epub 2021 Oct 14. PMID: 34656688. 前列腺癌患者的...
Mugoni V, Ciani Y, Nardella C, Demichelis F. Circulating RNAs in prostate cancer patients. Cancer Lett. 2022 Jan 1;524:57-69. doi: 10.1016/j.canlet.2021.10.011. Epub 2021 Oct 14. PMID: 34656688. 前列腺癌患者的循环 RNA •细胞外 RNA 分子 (...
前列腺癌患者的CirculatingRNAs循环材料的收集和分析通常称为液体活检与实体癌特别相关因为它原则上提供了通过抽血评估恶性组织存在的机会同时限制侵入性程序即针活检或用于身体扫描的高分辨率成像方式即pet 前列腺癌患者的CirculatingRNAs Circulating RNAs in prostate cancer patients Mugoni V, Ciani Y, Nardella C, Demi...
Circulating RNAs in prostate cancer patientsdoi:10.1016/j.canlet.2021.10.011Vera MugoniYari CianiCaterina NardellaFrancesca DemichelisCancer Letters
Micro (mi)RNAs are small RNA species whose expression is often dysregulated in cancer. MiRNAs are present in the circulation of cancer patients and can potentially be used for disease monitoring. Large proportion of circulating miRNAs in cancer patients do not originate from tumors but rather reflec...
Circulating RNAs in prostate cancer patients 2022, Cancer Letters Citation Excerpt : More recently, few attempts were made to deconvolve EVs transcriptomics populations from liquid biopsies [143,144]. The EV-Origin algorithm has been used to predict the relative enrichment of hemopoietic cells and sol...
Small non-coding RNAs (sncRNA) are regulators of cell functions and circulating sncRNAs from the majority of RNA classes are potential non-invasive biomarkers. Understanding how common traits influence ncRNA expression is essential for assessing their biomarker potential. In this study, we identify ass...
there remain a number of challenges yet to be overcome in the management of prostate cancer. The increasing use of PSA-based screening has facilitated the early detection of prostate cancer at a curable stage of the disease, however the problem of determining which of these patients truly require...
Finally, we highlight the potential of circulating miRNAs in clinical applications for cancer.Introduction MiRNAs are a class of small, single-stranded non-coding RNAs of 19–24 nt in length that primarily function at the posttranscriptional level [1]–[4]. MiRNAs function in many biological ...
In the current era of precision medicine, the identification of genomic alterations has revolutionised the management of patients with solid tumours. Recent advances in the detection and characterisation of circulating tumour DNA (ctDNA) have enabled the